Section 1532 - Statements to accompany significant regulatory actions

1 Citing brief

  1. Cyclops Vapor 2, Llc et al v. United States Food And Drug Administration et Al(Mag2)

    BRIEF/MEMORANDUM in Support re MOTION for Summary Judgment

    Filed February 1, 2017

    In addition, agencies must prepare “a qualitative and quantitative assessment of the anticipated costs and benefits of [a rule], including the costs and benefits to ... the private sector” whenever a rule will impose over $100 million in inflation-adjusted costs. 2 U.S.C. § 1532(a)(2). The APA’s requirement of “reasoned decision making” likewise requires agencies to “look at the costs as well as the benefits” of the rules they promulgate.